Telemedicine Feasible for Buprenorphine Initiation in Opioid Use Disorder
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
MONDAY, Oct. 23, 2023 -- Patients may benefit from the use of telemedicine during buprenorphine initiation for opioid use disorder (OUD) when compared with traditional initiation, according to a study published online Oct. 18 in JAMA Network Open.
Lindsey R. Hammerslag, Ph.D., from the University of Kentucky in Lexington, and colleagues examined associations between transmucosal buprenorphine OUD treatment modality (telemedicine versus traditional) during the COVID-19 public health emergency and the health outcomes of treatment retention and opioid-related nonfatal overdose. The analysis included Medicaid claims and enrollment data from 41,266 individuals in Kentucky and 50,648 individuals in Ohio (Nov. 1, 2019, to Dec. 31, 2020).
The researchers found that telemedicine buprenorphine initiations increased sharply at the beginning of 2020. Telemedicine initiation was associated with better odds of 90-day retention with buprenorphine in both states (adjusted odds ratios [95 percent confidence intervals], 1.13 [1.01 to 1.27] and 1.19 [1.06 to 1.32] for Kentucky and Ohio, respectively) when adjusting for patient demographic and comorbidity characteristics. There was no association seen between telemedicine initiation and opioid-related nonfatal overdose (adjusted odds ratios [95 percent confidence intervals], 0.89 [0.56 to 1.40] and 1.08 [0.83 to 1.41] for Kentucky and Ohio, respectively).
"These findings add to the literature demonstrating positive outcomes associated with the use of telemedicine for treatment of OUD," the authors write.
Several authors disclosed ties to industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
People With Opioid Use Disorder Less Likely to Receive Palliative Care
MONDAY, April 29, 2024 -- People with opioid use disorder (OUD) are less likely to receive palliative care during the last 90 days before death, according to a study published...
Seven in 10 Experiencing Homelessness Have a Mental Health Disorder
WEDNESDAY, April 17, 2024 -- The majority of people experiencing homelessness have mental health disorders, according to a review published online April 17 in JAMA...
Midlife Deaths of Despair Increased From 1999 to 2022
THURSDAY, April 11, 2024 -- Midlife deaths from suicide, drug overdose, and alcoholic liver disease, collectively known as deaths of despair, increased from 1999 through 2022...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.